Department of Dermatology, Emory University, Atlanta, GA 30322, USA.
Transplant Rev (Orlando). 2010 Oct;24(4):172-89. doi: 10.1016/j.trre.2010.05.002. Epub 2010 Aug 14.
Skin cancers occur more frequently in solid organ transplant recipients relative to the general population. Transplant recipients are at particularly high risk of squamous cell carcinoma, with up to a 100-fold increase in the relative risk when compared to the nontransplanted population. This compares with a 10- to 16-fold increase in basal cell carcinoma for renal transplant recipients. An increased incidence of melanoma in transplant patients has also been reported. Other types of skin cancer associated with immunosuppression in transplant patients include Kaposi sarcoma, Merkel cell carcinoma, and posttransplant lymphoproliferative disorder. This review discusses the epidemiology and pertinent pathologic features of each of these tumors. A brief clinical management strategy is outlined. In addition, the contribution of viral induced carcinogenesis with respect to Kaposi sarcoma, Merkel cell carcinoma, and posttransplant lymphoproliferative disorder is discussed.
皮肤癌在实体器官移植受者中的发病率高于普通人群。与非移植人群相比,移植受者罹患鳞状细胞癌的风险特别高,相对风险高达 100 倍。相比之下,肾移植受者基底细胞癌的风险增加了 10 到 16 倍。也有报道称,黑色素瘤在移植患者中的发病率增加。与移植患者免疫抑制相关的其他类型皮肤癌包括卡波西肉瘤、默克尔细胞癌和移植后淋巴组织增生性疾病。这篇综述讨论了这些肿瘤的流行病学和相关病理特征。概述了一个简要的临床管理策略。此外,还讨论了病毒诱导的致癌作用与卡波西肉瘤、默克尔细胞癌和移植后淋巴组织增生性疾病的关系。